Literature DB >> 6491670

Degradation of NAD by synaptosomes and its inhibition by nicotinamide mononucleotide: implications for the role of NAD as a synaptic modulator.

C R Snell, P H Snell, C D Richards.   

Abstract

We have found NAD to be rapidly degraded by extracellular enzymes present on intact rat brain synaptosomes. The enzyme involved had the specificity of an NADase cleaving the molecule at the nicotinamide-glycoside linkage and was inhibited by nicotinamide mononucleotide (NMN). This inhibitor did not displace specific binding of NAD to rat brain membranes or affect electrical activity in the guinea pig hippocampus. Therefore, inclusion of NMN in binding assays allowed unambiguous demonstration of two specific NAD binding sites on rat brain synaptosomal membranes (KD1, 82 nM, KD2, 1.98 microM). The depressant action of NAD on the evoked synaptic activity of the guinea pig hippocampus was not blocked after inhibition of NAD degradation with NMN. The physiological implications of these results for the function of NAD as a neurotransmitter or neuromodulator in the CNS are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491670     DOI: 10.1111/j.1471-4159.1984.tb06085.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  Extracellular synthesis of cADP-ribose from nicotinamide-adenine dinucleotide by rat cortical astrocytes in culture.

Authors:  L Pawlikowska; S E Cottrell; M B Harms; Y Li; P A Rosenberg
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

2.  Relationship of metabolism of 2'-, 3'- and 5'-adenine nucleotides to presynaptic inhibition of transmitter release in rat vas deferens.

Authors:  D R Webster; G D Boston; N H Holford; D M Paton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

3.  Visualization and quantification of NAD(H) in brain sections by a novel histo-enzymatic nitrotetrazolium blue staining technique.

Authors:  Irina S Balan; Gary Fiskum; Tibor Kristian
Journal:  Brain Res       Date:  2009-12-28       Impact factor: 3.252

4.  Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.

Authors:  Aaron N Long; Katrina Owens; Anna E Schlappal; Tibor Kristian; Paul S Fishman; Rosemary A Schuh
Journal:  BMC Neurol       Date:  2015-03-01       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.